Our results supplied direct experimental data showing that ovarian topical administration of the follicle‐activating drug EGF improved the activation and development of follicles in the murine ovaries of normal and induced premature ovarian failure model mice, which represented a possibility of a novel infertility treatment strategy for both aged women and women with ovarian diseases. Here, EGF is linked to primary ovarian failure.